Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 2
2(50.0%)
N/A
2(50.0%)
4Total
Phase 2(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04824365Phase 2Completed

Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection

Role: collaborator

NCT05114993Not ApplicableCompleted

The Effect of Wearing Masks on End-tidal Carbon Dioxide and Pulse Oximetry

Role: collaborator

NCT04871815Phase 2Completed

Effects of Sodium Pyruvate Nasal Spray in COVID-19 Long Haulers.

Role: collaborator

NCT03551925Not ApplicableCompleted

Effect of Occupational Therapy in Promoting Medication Adherence

Role: collaborator

All 4 trials loaded